Abstract
In the oocyte donation program at Columbia University we have found an increasing interest on the part of recipients about the genetic background of their donors. This is most likely due to the increased public awareness of the role of genetics in human behavior and disease. Recipients, being mostly well educated, are aware that new testing for a variety of genetic diseases is available. Many have very specific ideas about which attributes they would like their donor to have (or not have). Although little has been written specifically on the subject of genetic screening of oocyte donors, from the clinical point of view there is little difference between egg and sperm donation. The genetic aspects of sperm donation have been considered by several authors over the past 15 years. Much of what has been written about the genetics of sperm donation applies to egg donation. However, many aspects of oocyte donation, such as its expense, shortage of available donors, and an inability to store eggs, make it difficult to reject potential donors as freely as one does sperm donors. This adds to the need to consider genetic aspects carefully. The following topics are discussed in this chapter:
-
1.
The role of the physician in the genetic screening of donors
-
2.
The accepted guidelines for donor screening
-
3.
The genetic principles upon which those guidelines are based
-
4.
A genetic screening protocol (Appendix A)
-
5.
The information that may be given to recipients about how donors are screened (Appendix B)
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Weisman AI. The selection of donors for use in artificial insemination. West J Surg. 1952; 50: 142.
Fraser FC, Forse RA. On genetic screening of donors for artificial insemination. Am J Med Genet. 1981; 10: 399–405.
Anonymous. Guidelines for gamete donation: 1993. The American Fertility Society. Fertil Steril. 1993; 59: 1S-9S.
Jalbert P, Leonard C, Selva J, David G. Genetic aspects of artificial insemination with donor semen: the French CECOS Federation guidelines. Am J Med Genet. 1989; 33: 269–275.
Zilberstein M, Verp MS. Genetic issues in gamete donation. In: Seibel MM, Crockin S, eds. Family Building through Egg and Sperm Donation. Boston: Jones & Bartlett; 1996: 94–105.
Timmons MC, Rao KW, Sloan CS, Kirkman HN, Talbert LM. Genetic screening of donors for artificial insemination. Fertil Steril. 1981; 35: 451–456.
Roa BB, Boyd AA, Volcik K, Richards CS. Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2. Nat Genet. 1996; 14: 185–187.
Oddoux C, Struewing JP, Clayton CM, et al. The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%. Nat Genet. 1996; 14: 188–190.
Evans HJ. Chromosome abnormalities among livebirths. J Med Genet. 1977; 14: 309–312.
Brown S, Warburton D. Recurrent abortion: genetic and other nonimmune factors. In: Reed GB, Claireaux AE, Cockburn F, eds. Diseases of the Fetus and Newborn. London: Chapman and Hall; 1995: 167–172.
Thompson MW, Mclnnes RR, Willard HF. Genetics in Medicine. Philadelphia: Saunders, 1991.
Weinshenker BG. Epidemiology of multiple sclerosis. Neurol Clin. 1996; 14: 291–308.
Baird PA, Anderson TW, Newcombe HB, Lowry RB. Genetic disorders in children and young adults: a population study. Am J Hum Genet. 1988; 42: 677–693.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer Science+Business Media New York
About this chapter
Cite this chapter
Brown, S. (1998). Genetic Aspects of Donor Selection. In: Sauer, M.V. (eds) Principles of Oocyte and Embryo Donation. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-1640-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4612-1640-7_5
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4612-7226-7
Online ISBN: 978-1-4612-1640-7
eBook Packages: Springer Book Archive